tiprankstipranks
Tarsus Pharmaceuticals price target raised to $65 from $63 at Oppenheimer
PremiumThe FlyTarsus Pharmaceuticals price target raised to $65 from $63 at Oppenheimer
3M ago
Tarsus Pharmaceuticals Reports Strong Q3 2024 Performance
Premium
Company Announcements
Tarsus Pharmaceuticals Reports Strong Q3 2024 Performance
3M ago
Closing Bell Movers: Tetra Tech down 8% after Q4 results, guidance
Premium
The Fly
Closing Bell Movers: Tetra Tech down 8% after Q4 results, guidance
3M ago
Tarsus Pharmaceuticals appoints Elizabeth Yeu as CMO
PremiumThe FlyTarsus Pharmaceuticals appoints Elizabeth Yeu as CMO
3M ago
Tarsus Pharmaceuticals rumor highlighted in Betaville blog
Premium
The Fly
Tarsus Pharmaceuticals rumor highlighted in Betaville blog
3M ago
Tarsus Pharmaceuticals management to meet with Oppenheimer
Premium
The Fly
Tarsus Pharmaceuticals management to meet with Oppenheimer
3M ago
Tarsus Pharmaceuticals price target raised to $60 from $50 at Barclays
PremiumThe FlyTarsus Pharmaceuticals price target raised to $60 from $50 at Barclays
9M ago
Tarsus Pharmaceuticals price target raised to $61 from $59 at Oppenheimer
Premium
The Fly
Tarsus Pharmaceuticals price target raised to $61 from $59 at Oppenheimer
9M ago
Tarsus Pharmaceuticals reports Q1 EPS  ($1.01), consensus ($1.20)
Premium
The Fly
Tarsus Pharmaceuticals reports Q1 EPS ($1.01), consensus ($1.20)
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100